» Articles » PMID: 1314384

The Gamma 1(34.5) Gene of Herpes Simplex Virus 1 Precludes Neuroblastoma Cells from Triggering Total Shutoff of Protein Synthesis Characteristic of Programed Cell Death in Neuronal Cells

Overview
Specialty Science
Date 1992 Apr 15
PMID 1314384
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

The gamma 1(34.5) gene of herpes simplex virus 1 was previously shown to play a role in viral virulence since deletion of the gene reduced by a factor of approximately 100,000 the capacity of the virus to replicate in the central nervous system and cause mortality in the mouse. Here we show that in the human neuroblastoma cell line SK-N-SH of neuronal origin gamma 1(34.5) null mutants expressed early proteins, viral DNA, and mRNA of late genes. However, the onset of viral DNA synthesis triggered complete cessation of incorporation of radioactive precursors into proteins. The mutant and wild-type viruses replicated and could not be differentiated in cell lines or cell strains of nonneuronal origin. The results indicate that in the absence of the gamma 1(34.5) gene the SK-N-SH neuroblastoma cells triggered a response similar to the programed cell death of neuronal cells induced by metabolic stress. The gamma 1(34.5) protein precludes this cell response possibly in order to enable the protein synthesis necessary for viral replication.

Citing Articles

Virus nanotechnology for intratumoural immunotherapy.

Omole A, Zhao Z, Chang-Liao S, de Oliveira J, Boone C, Sutorus L Nat Rev Bioeng. 2024; 2(11):916-929.

PMID: 39698315 PMC: 11655125. DOI: 10.1038/s44222-024-00231-z.


The investigation of oncolytic viruses in the field of cancer therapy.

Yuan Z, Zhang Y, Wang X, Wang X, Ren S, He X Front Oncol. 2024; 14:1423143.

PMID: 39055561 PMC: 11270537. DOI: 10.3389/fonc.2024.1423143.


Induction of necroptosis in multinucleated giant cells induced by conditionally replicating syncytial oHSV in co-cultures of cancer cells and non-cancerous cells.

Suzuki T, Uchida H Mol Ther Oncol. 2024; 32(2):200803.

PMID: 38706990 PMC: 11067338. DOI: 10.1016/j.omton.2024.200803.


Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy.

Palomaki J, Kalke K, Orpana J, Lund L, Frejborg F, Paavilainen H Microorganisms. 2023; 11(11).

PMID: 38004669 PMC: 10673056. DOI: 10.3390/microorganisms11112657.


Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models.

Inoue K, Ito H, Iwai M, Tanaka M, Mori Y, Todo T Mol Ther Oncolytics. 2023; 30:72-85.

PMID: 37583387 PMC: 10423690. DOI: 10.1016/j.omto.2023.07.002.


References
1.
Ackermann M, Chou J, Sarmiento M, Lerner R, Roizman B . Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome. J Virol. 1986; 58(3):843-50. PMC: 252991. DOI: 10.1128/JVI.58.3.843-850.1986. View

2.
Duke R, Cohen J . IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res. 1986; 5(4):289-99. View

3.
Honess R, Roizman B . Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell. J Virol. 1973; 12(6):1347-65. PMC: 356776. DOI: 10.1128/JVI.12.6.1347-1365.1973. View

4.
Mocarski E, Post L, Roizman B . Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell. 1980; 22(1 Pt 1):243-55. DOI: 10.1016/0092-8674(80)90172-5. View

5.
Yamaguchi T, Kaufman H, Tognon M, Roizman B . Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J Exp Med. 1982; 155(2):475-89. PMC: 2186589. DOI: 10.1084/jem.155.2.475. View